摘要
Osteosarcoma(OS)is the most common primary bone cancer in children and adolescents,affecting~560 young patients in the United States annually.The term OS describes a diverse array of subtypes with varying prognoses,but the majority of tumors are high grade and aggressive.Perhaps because the true etiology of these aggressive tumors remains unknown,advances in OS treatment have reached a discouraging plateau,with only incremental improvements over the past 40 years.Thus,research surrounding the pathogenesis of OS is essential,as it promises to unveil novel therapeutic targets that can attack tumor cells with greater specificity and lower toxicity.Among the candidate molecular targets in OS,the retinoblastoma(RB)pathway demonstrates the highest frequency of inactivation and thus represents a particularly promising avenue for molecular targeted therapy.This review examines the present thinking and practices in OS treatment and specifically highlights the relevance of the RB pathway in osteosarcomagenesis.Through further investigation into RB pathway-related novel therapeutic targets,we believe that a near-term breakthrough in improved OS prognosis is possible.
